Core Insights - Huawei has successfully transitioned its smartwatch from a "health sentinel" to a "wrist blood pressure expert" by achieving medical-grade accuracy in blood pressure monitoring, which is now recognized for medical diagnostic reference [1][3]. Group 1: Product Development and Innovation - The Huawei WATCH D series has evolved from the first medical device certification in 2021 to the world's first dynamically certified blood pressure smartwatch, addressing a significant public health issue with 245 million hypertension patients in China [3][4]. - The WATCH D2 integrates traditional medical measurement techniques with innovative technology, combining oscillometric methods with a micro inflatable cuff to ensure accurate blood pressure readings [5][12]. - The WATCH D2 has received seven global medical certifications, including from the Chinese National Medical Products Administration, confirming its clinical accuracy comparable to professional medical devices [5][6]. Group 2: Addressing Market Needs - Huawei's WATCH D2 addresses long-standing challenges in hypertension management, such as the need for continuous monitoring and the limitations of traditional blood pressure measurement methods [9][10]. - The device allows for automatic blood pressure measurements throughout the day and night, achieving over 85% effective reading rates within 24 hours, thus facilitating better hypertension management [12][13]. Group 3: Comprehensive Health Management - The WATCH D2 offers tailored blood pressure management features, including reminders for regular measurements and the ability to generate detailed health reports analyzed by healthcare professionals [13][14]. - The device supports a one-click micro health check that provides a comprehensive health report in about 60 seconds, covering various health metrics, including emotional and cardiovascular health [14][15]. Group 4: Market Position and Future Outlook - Huawei has established itself as a leader in the wearable device market, with over 200 million devices sold globally and a 20.2% market share, making it the top brand in both global and Chinese smartwatch markets [16]. - The company aims to further innovate in the health monitoring space, transitioning smartwatches from consumer electronics to professional health devices, thus enhancing their role in chronic disease management [16].